Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Drug
InnoCare Pharma’s Hibruka Receives HSA Approval for Mantle Cell Lymphoma in Singapore
January 30, 2025
Company
Deals
Sun-Novo Pharma to Acquire MAH Rights for Azilsartan from Baiao Pharma
January 30, 2025
Company
Deals
UB Biotechnology Secures Series A Funding for Flow Cytometry Platform
January 30, 2025
Company
Deals
IASO Biotherapeutics Partners with Umoja Biopharma to Evaluate iCIL Platform
January 30, 2025
Policy / Regulatory
Shanghai Unveils Policies to Boost Global Biomedical R&D Hub
January 30, 2025
Company
WuXi Biologics Launches Integrated Biologics CRDMO Center in Shanghai
January 30, 2025
Company
Deals
Nona Biosciences Licenses HCAb Technology to Dragonfly Therapeutics
January 30, 2025
Company
Drug
Salubris Pharmaceuticals’ SAL0119 Accepted for CDE Review in China
January 30, 2025
Company
Drug
Aosaikang’s ASKG915 Accepted for FDA Review, Targets Advanced Solid Tumors
January 30, 2025
Company
Drug
Legend Biotech Receives IND Approval for LB2102 CAR-T Therapy
January 30, 2025
Company
Drug
Sun-Novo Pharma Gains NMPA Approval for STC007 Clinical Study in CKD-aP
January 30, 2025
Company
Deals
JD Healthcare Partners with Jiangsu Yuyue for Medical Device Collaboration
January 30, 2025
1
2
…
1,087
1,088
1,089
1,090
1,091
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
